DSM-Firmenich, a leading global player in the food and nutrition industry, has announced a strategic partnership with ExoLab Italia, a start-up that specializes in plant-derived exosomal technologies. This collaboration is seen as pivotal moment in the broader strategy for innovation and sustained growth by officials.
Emmanuel Butstraen, president perfumery and beauty at DSM-Firmenich, stated that the collaboration aligns with the company’s commitment to providing customers with the highest quality products that meet the growing demand for natural, effective, and sustainable ingredients in the skincare market.
Exosomes are extracellular vesicles naturally released by cells in all living organisms, serving as a natural delivery system for molecules produced by cells and facilitating intercellular communication. Plant-derived exosomes offer numerous benefits for personal care and beauty products, as well as skin health. They are rich in antioxidants, vitamins, proteins, lipids, and messenger molecules that work together to enhance skin health and combat signs of aging.
ExoLab Italia is known for its expertise in exosomal technologies and is dedicated to advancing nutraceutical supplements, cosmetic products, and healthcare solutions. By focusing on plant-derived exosomes, ExoLab Italia offers distinctive scientific proficiency in cellular health and skin recovery. This expertise combined with DSM-Firmenich’s renowned knowledge in skin biology, claim substantiation, and active ingredients presents immense potential to elevate the standards of natural and effective skincare to unprecedented heights according to Gabriele Campi CEO of ExoLab Italia.
